Previous research has shown that CD36 promotes the transport of oxLDL into double-negative regulatory T cells, inducing ferroptosis in these cells, which subsequently exacerbates liver immune homeostasis disruption and the progression of metabolic dysfunction-associated steatotic liver disease [47]. Here, CD36 is linked to liver disorder.